CTRI/2022/02/040212尚未招募3 期
Pre-habilitation in ovarian cancer cytoreductive surgery and its effect on postoperative morbidity (PROSPERITY): A randomized controlled trial - PROSPERITY
Cancer Institute0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Age > 18 years
- •2. Patients awaiting elective cytoreductive surgeries for ovarian cancer after completion of the due course of chemotherapy.
- •3.Time to surgery 2 to 6 weeks.
排除标准
- •1.Laparoscopic surgery
- •2.Heart disease with positive stress test
- •3.Chronic pulmonary disease with dyspnoea at exertion.
- •4.Limb immobility
- •5.Hemoglobin <7 g/dl
- •6.Acute infection
- •7.Known hypersensitivity to any drugs or to parenteral iron
- •8.Bronchial asthma
- •9.Chronic liver disease with SGOT, SGPT >3 times the upper limit of normal
- •10.Renal disease requiring dialysis
- •11.Inability to comprehend and perform the exercise interventions
- •12.Active bleeding from tumour
- •13.Massive ascites /pleural effusion refractory after the last cycle of chemotherapy
- •14.Patients for primary surgery will be excluded.(Surgery before chemotherapy)
研究者
相似试验
已完成
不适用
SOPHIE Trial: Surgery in Ovarian Cancer With PreHabilitation In ERASAdvanced Ovarian CancerNCT04862325Hospital Clinic of Barcelona158
已完成
不适用
Early detection of ovarian cancer and response prediction: TEP and ctDNA study.ovarian tumorNL-OMON50170Catharina-ziekenhuis200
终止
不适用
Ovarian Freezing Before Cancer TreatmentEffects of ChemotherapyNCT01057745University of Pennsylvania31
已完成
不适用
The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Ovarian CancerOvarian CancerNCT02856841Cairo University44
招募中
不适用
Clinical Pre-screening Protocol for Ovarian CancerOvarian CancerNCT03877796Allarity Therapeutics60